PAULA HERNANDEZ: Open Payments
NPI 1316559289 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$904 in 37 payments from 12 companies in 2025. Trend: 2023 $572 · 2024 $1,036 · 2025 $904
Food & beverage: $904
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $262 |
| Lilly USA, LLC | 7 | $114 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $102 |
| Novo Nordisk Inc | 4 | $83 |
| Abbott Laboratories | 2 | $70 |
| ABBVIE INC. | 3 | $67 |
| Edwards Lifesciences Corporation | 1 | $60 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| Lundbeck LLC | 2 | $28 |
Products named: AIRSUPRA, Kerendia, MOUNJARO, REXULTI, Ozempic, SAPIEN 3 Ultra RESILIA, AVEIR, TRELEGY ELLIPTA.
Industry payments across AZ — which companies pay providers there.
